University of Tasmania
Browse

File(s) under permanent embargo

Analysis of cerebrospinal fluid for xanthochromia in the investigation of subarachnoid haemorrhage: experience of a state-wide, tertiary referral trauma centre

conference contribution
posted on 2023-05-24, 21:08 authored by Simon HandleySimon Handley, Viet TranViet Tran

Introduction: Subarachnoid haemorrhage (SAH) is associated with high mortality and morbidity. To aid diagnosis, cerebrospinal fluid (CSF) can be examined for xanthochromia (yellow discoloration, indicating the presence of bilirubin). The Department of Pathology, Royal Hobart Hospital offers a state-wide service for the detection of CSF xanthochromia. CSF xanthochromia results from the current service were audited to assess clinical utility.

Methods: We reviewed CSF xanthochromia results from samples received over a two-year period. Data reviewed included the date and time of: initial Non Contrast-Computed Tomography of the Brain (NC-CTB) scan, CSF sample collection, sample receipt in the laboratory, release of result to the clinician, and when the patient was discharged from the hospital. Xanthochromia in CSF was determined by spectrophotometry.

Results: Sixty-nine CSF samples were tested for xanthochromia. In no sample was xanthochromia positively identified by spectrophotometry. No patient had a diagnosis of SAH by NCCTB. Three-quarters (74%) of these samples were analysed within normal working hours. For these samples, the median time for sample analysis and reporting of the result after receipt into the laboratory was 4 hours. Median (range) time from onset of symptoms to CSF collection was 32 (10-241) hours. One-third (29%) of patients were discharged from the hospital 28-61 (median 20) hours prior to the CSF xanthochromia result being reported. Eighteen samples were analysed 'out of hours' as urgent requests. All patients except 1 were discharged after receiving the negative CSF xanthochromia result (median 3, range <1-282 hours).

Conclusion: Our study confirms the low detection rate of SAH by CSF xanthochromia. A significant number of patients being discharged prior to release of the xanthochromia result were identified. A more targeted approach to the utilisation of CSF xanthochromia testing requested during normal working hours should be pursued.

History

Publication title

Proceedings of the Australasian Association of Clinical Biochemistry and Laboratory Medicine’s 2020 Virtual Scientific Conference

Pagination

S15-S16

ISSN

0159-8090

Department/School

Tasmanian School of Medicine

Publisher

Australasian Association for Clinical Biochemistry and Laboratory Medicine

Place of publication

Australia

Event title

57th Australasian Association of Clinical Biochemistry and Laboratory Medicine Annual Scientific Conference

Event Venue

Online Web Conference

Date of Event (Start Date)

2020-10-27

Date of Event (End Date)

2020-10-28

Repository Status

  • Restricted

Socio-economic Objectives

Other health not elsewhere classified

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC